SILO Pharma Inc.

SILO Pharma Inc.https://investorshangout.com/SILO-Pharma-Inc-SILO-87596/en-usThu, 29 Oct 2026 18:33:52 GMTCopyright InvestorsHangout.comNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances SPC-15 Intranasal PTSD Program With https://investorshangout.com/post/view?id=6835988https://investorshangout.com/post/view?id=6835988Tue, 30 Jun 2026 20:29:14 GMTlouied91: $SILO $HOTH Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeuticshttps://investorshangout.com/post/view?id=6772322https://investorshangout.com/post/view?id=6772322Wed, 25 Jun 2025 14:05:14 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Working to Deliver Novel Treatment for Chronihttps://investorshangout.com/post/view?id=6589142https://investorshangout.com/post/view?id=6589142Fri, 23 Jun 2023 20:07:54 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Secures US Patent for SPU-21 Treatment for Auhttps://investorshangout.com/post/view?id=6588208https://investorshangout.com/post/view?id=6588208Wed, 21 Jun 2023 20:54:33 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Awarded U.S. Patent Protecting Ongoing R&D ofhttps://investorshangout.com/post/view?id=6572760https://investorshangout.com/post/view?id=6572760Tue, 09 May 2023 20:49:30 GMTNetworkNewsWire: Silo Pharma Inc. (NASDAQ: SILO) Provides Update on Innovative Study Looking into the Feasibility https://investorshangout.com/post/view?id=6553979https://investorshangout.com/post/view?id=6553979Tue, 28 Mar 2023 20:42:36 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Files Patent for Treatment of Fibromyalgiahttps://investorshangout.com/post/view?id=6553476https://investorshangout.com/post/view?id=6553476Mon, 27 Mar 2023 19:55:53 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Positioned as Frontrunner in Psychedelic Drughttps://investorshangout.com/post/view?id=6552657https://investorshangout.com/post/view?id=6552657Fri, 24 Mar 2023 21:08:31 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Positive Results from IND-Enabling https://investorshangout.com/post/view?id=6548757https://investorshangout.com/post/view?id=6548757Wed, 15 Mar 2023 19:38:09 GMTNetworkNewsWire: Silo Pharma Inc. (NASDAQ: SILO) Set to Benefit as Study Supports the Efficacy of Psychedelics in https://investorshangout.com/post/view?id=6547856https://investorshangout.com/post/view?id=6547856Mon, 13 Mar 2023 21:17:04 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expands Intellectual Property, Technology Righttps://investorshangout.com/post/view?id=6544353https://investorshangout.com/post/view?id=6544353Fri, 03 Mar 2023 21:17:21 GMTNetworkNewsWire: Silo Pharma Inc. (NASDAQ: SILO) Granted US Patent For SPC-15 to Prevent and Treat Stress-Induced https://investorshangout.com/post/view?id=6540197https://investorshangout.com/post/view?id=6540197Wed, 22 Feb 2023 20:26:23 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Files Patent for Treatment of Alzheimer’shttps://investorshangout.com/post/view?id=6536267https://investorshangout.com/post/view?id=6536267Mon, 13 Feb 2023 21:08:26 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Partnering to Transform Health Care, Improve https://investorshangout.com/post/view?id=6533534https://investorshangout.com/post/view?id=6533534Tue, 07 Feb 2023 20:57:07 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expands IP Portfolio with New USPTO Patent https://investorshangout.com/post/view?id=6531205https://investorshangout.com/post/view?id=6531205Thu, 02 Feb 2023 20:30:00 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Board Authorizes Stock Repurchase Programhttps://investorshangout.com/post/view?id=6530086https://investorshangout.com/post/view?id=6530086Tue, 31 Jan 2023 21:17:25 GMTNetworkNewsWire: Silo Pharma Inc. (NASDAQ: SILO) Provides Update on UCSF Psylocibin Clinical Trial - SILO rhttps://investorshangout.com/post/view?id=6527938https://investorshangout.com/post/view?id=6527938Thu, 26 Jan 2023 21:04:26 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Eying Broad Market Opportunities for Its Lipohttps://investorshangout.com/post/view?id=6525262https://investorshangout.com/post/view?id=6525262Fri, 20 Jan 2023 20:23:11 GMTNetworkNewsWire: Silo Pharma Inc. (NASDAQ: SILO) Provides Positive Update on Ongoing Study into the Use of Joint Hhttps://investorshangout.com/post/view?id=6522209https://investorshangout.com/post/view?id=6522209Thu, 12 Jan 2023 20:36:51 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advancing Research of SPU-21 in Human Synoviahttps://investorshangout.com/post/view?id=6501471https://investorshangout.com/post/view?id=6501471Mon, 21 Nov 2022 20:40:29 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Milestone in IND-Enabling Study of https://investorshangout.com/post/view?id=6497237https://investorshangout.com/post/view?id=6497237Fri, 11 Nov 2022 21:02:18 GMTNetworkNewsWire: New Psychedelic Journal to Focus on Publishing Psychedelic Research The psychedelic medicihttps://investorshangout.com/post/view?id=6495167https://investorshangout.com/post/view?id=6495167Mon, 07 Nov 2022 22:35:26 GMTNetworkNewsWire: Silo Pharma Inc. (NASDAQ: SILO) Extends Columbia University Agreement to Continue Research for Thhttps://investorshangout.com/post/view?id=6494313https://investorshangout.com/post/view?id=6494313Fri, 04 Nov 2022 20:53:02 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Confident in Preclinical Work on Its Novel Kehttps://investorshangout.com/post/view?id=6493689https://investorshangout.com/post/view?id=6493689Thu, 03 Nov 2022 19:31:32 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) to Present at Largest Gathering in Psychedelihttps://investorshangout.com/post/view?id=6489959https://investorshangout.com/post/view?id=6489959Wed, 26 Oct 2022 21:06:40 GMTNetworkNewsWire: What You Should Know About Colorado’s Psychedelics Ballot Measure Psychedelic drugs, whichhttps://investorshangout.com/post/view?id=6488996https://investorshangout.com/post/view?id=6488996Mon, 24 Oct 2022 20:35:14 GMTNetworkNewsWire: Silo Pharma Inc.’s (NASDAQ: SILO) Novel Ketamine Formulation Undergoing Safety Evaluation, Pursuihttps://investorshangout.com/post/view?id=6488979https://investorshangout.com/post/view?id=6488979Mon, 24 Oct 2022 20:05:07 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Distinctive with Ground-Breaking Research, Cohttps://investorshangout.com/post/view?id=6488970https://investorshangout.com/post/view?id=6488970Mon, 24 Oct 2022 19:52:59 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Data Supporting SPC-14’s Therapeutihttps://investorshangout.com/post/view?id=6487885https://investorshangout.com/post/view?id=6487885Thu, 20 Oct 2022 20:04:17 GMTNetworkNewsWire: Florida Dispensary Uncovers Legal Loophole, Starts Selling Shrooms Last month, a hemp disphttps://investorshangout.com/post/view?id=6486731https://investorshangout.com/post/view?id=6486731Tue, 18 Oct 2022 20:38:16 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Agreement with Columbia University https://investorshangout.com/post/view?id=6486693https://investorshangout.com/post/view?id=6486693Tue, 18 Oct 2022 19:52:11 GMTNetworkNewsWire: Legislators in New York File Revised Measure to Legalize Psychedelics Legislators in the shttps://investorshangout.com/post/view?id=6484252https://investorshangout.com/post/view?id=6484252Wed, 12 Oct 2022 21:01:41 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Initiates Safety Evaluation Study of Its Novehttps://investorshangout.com/post/view?id=6483002https://investorshangout.com/post/view?id=6483002Mon, 10 Oct 2022 20:56:17 GMTNetworkNewsWire: Researchers Develop Psychedelic Compound with No Hallucinogenic Effects, Can Treat Depressionhttps://investorshangout.com/post/view?id=6481737https://investorshangout.com/post/view?id=6481737Thu, 06 Oct 2022 21:26:14 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) to Participate at Upcoming Dawson James Smallhttps://investorshangout.com/post/view?id=6481673https://investorshangout.com/post/view?id=6481673Thu, 06 Oct 2022 19:20:12 GMTNetworkNewsWire: Silo Pharma Inc. (NASDAQ: SILO) Successfully Uplists, Commences Trading on the Nasdaq Market https://investorshangout.com/post/view?id=6481105https://investorshangout.com/post/view?id=6481105Wed, 05 Oct 2022 20:16:55 GMTNetworkNewsWire: How Psychedelic Integration Coaches Help Facilitate Healing The psychiatry space is all abhttps://investorshangout.com/post/view?id=6480578https://investorshangout.com/post/view?id=6480578Tue, 04 Oct 2022 21:00:04 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Preparing for Ketamine Tech FDA Pre-Investigahttps://investorshangout.com/post/view?id=6479903https://investorshangout.com/post/view?id=6479903Mon, 03 Oct 2022 20:45:30 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Preparing for Ketamine Tech FDA Pre-Investigahttps://investorshangout.com/post/view?id=6479902https://investorshangout.com/post/view?id=6479902Mon, 03 Oct 2022 20:45:11 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Secures $5.75M in Underwritten Public Offerinhttps://investorshangout.com/post/view?id=6479031https://investorshangout.com/post/view?id=6479031Fri, 30 Sep 2022 19:20:04 GMTNetworkNewsWire: Breakthrough Test May Make It Easier to Diagnose Parkinson’s Using Skin Swabs Researchers https://investorshangout.com/post/view?id=6478552https://investorshangout.com/post/view?id=6478552Thu, 29 Sep 2022 20:54:16 GMTNetworkNewsWire: Psychedelics Feature During Congressional Ways and Means Committee Meeting Last week, Rep.https://investorshangout.com/post/view?id=6477953https://investorshangout.com/post/view?id=6477953Wed, 28 Sep 2022 21:44:43 GMTNetworkNewsWire: NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Uplisting to Nasdaq Capital Market,https://investorshangout.com/post/view?id=6477388https://investorshangout.com/post/view?id=6477388Tue, 27 Sep 2022 21:08:25 GMTSteel Reserve: SILO reverse split, 9/15/2022: 1:50 https://investorshangout.com/post/view?id=6471145https://investorshangout.com/post/view?id=6471145Thu, 15 Sep 2022 15:50:13 GMTNetworkNewsWire: Study Finds Depression Symptoms in Partners Caring for Dementia Patients May Start Long Before Cohttps://investorshangout.com/post/view?id=6470719https://investorshangout.com/post/view?id=6470719Wed, 14 Sep 2022 21:17:03 GMTNetworkNewsWire: Georgia Legislators Discuss Psychedelics for Veterans During Committee Hearing Hallucinogehttps://investorshangout.com/post/view?id=6470079https://investorshangout.com/post/view?id=6470079Tue, 13 Sep 2022 20:31:24 GMTNetworkNewsWire: New Research Finds Link Between Psychedelic-Induced Mystical Experiences and EcoFriendly Behaviorhttps://investorshangout.com/post/view?id=6467754https://investorshangout.com/post/view?id=6467754Thu, 08 Sep 2022 20:52:46 GMTNetworkNewsWire: Research Indicates Better Sleep Efficiency Benefits Fibromyalgia Sufferers New research hahttps://investorshangout.com/post/view?id=6466442https://investorshangout.com/post/view?id=6466442Tue, 06 Sep 2022 21:07:52 GMTNetworkNewsWire: Important Factors to Consider When Designing Psychedelic Clinical Trial Protocols Companiehttps://investorshangout.com/post/view?id=6465222https://investorshangout.com/post/view?id=6465222Fri, 02 Sep 2022 20:59:28 GMTNetworkNewsWire: Psychedelics Company Raises More than $10M in Seed Funding to Advance Ketamine Therapy Frehttps://investorshangout.com/post/view?id=6463165https://investorshangout.com/post/view?id=6463165Tue, 30 Aug 2022 21:19:31 GMT